Market size in 2023 | US$ 188.6 billion |
Forecast Market size by 2030 | US$ 355.3 billion |
---|---|---|---|
Growth Rate | CAGR of 8.8% | Number of Pages | 85 Pages |
The global Immunotherapy market was valued at US$ 188.6 billion in 2023 and is projected to reach US$ 355.3 billion by 2030, at a CAGR of 8.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report studies the Immunotherapy market, covering market size for segment by type (Monoclonal Antibodies, Vaccines, etc.), by application (Cancer, Infectious Diseases, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AbbVie, Merck, Pfizer, Roche, Bristol-Myers Squibb, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Immunotherapy from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Immunotherapy market.
Leading Players of Immunotherapy including:
Market split by Type:
Market split by Application:
Market split by Sales Channel:
Market split by Region/Country:
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Report Attributes | Report Details |
---|---|
Report Title | Immunotherapy Market by Player, Region, Type, Application and Sales Channel 2024-2030 |
Market size in 2023 | US$ 188.6 billion |
Forecast Market size by 2030 | US$ 355.3 billion |
Growth Rate | CAGR of 8.8% |
Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year | 2023 |
Forecast Year | 2031 |
Number of Pages | 85 Pages |
Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?